References
- Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008.
- Grimaldi JC, Meeker TC. The t(5;14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleukin-3 gene to the immunoglobulin heavy chain gene. Blood. 1989;73:2081–2085.
- Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–2405.
- Tono-oka T, Sato Y, Matsumoto T, et al. Hypereosinophilic syndrome in acute lymphoblastic leukemia with a chromosome translocation [t(5q;14q)]. Med Pediatr Oncol. 1984;12:33–37.
- George S, Kumar P, Quarta G, et al. Loeffler myocarditis in pre-B acute lymphoblastic leukaemia with t(5;14)(q31;q32). Br J Haematol. 2012;157:517.
- Kaneko H, Shimura K, Yoshida M, et al. Acute lymphoblastic leukemia with eosinophilia lacking peripheral blood leukemic cell: a rare entity. Indian J Hematol Blood Transfus. 2014;30(Suppl.1):80–83.
- Toboso DG, Campos CB. Peripheral eosinophilia as the first manifestation of B-cell acute lymphoblastic leukemia with t(5;14)(q31;q32). Blood. 2017;130:380.
- Bomken S, Haigh S, Bown N, et al. Cutaneous B-lymphoblastic lymphoma with IL3/IgH translocation presenting with hypereosinophilia and acute endocarditis. Pediatr Blood Cancer. 2015;62:1055–1057.
- Gotlib J. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management. Am J Hematol. 2014;89:325–337.
- Schiavinato A, Piva E, Pantano G, et al. A case of eosinophilic disorder that evolved in acute lymphoblastic leukemia. Am J Hematol. 2016;91:167–168.
- Beldjord K, Chevret S, Asnafi V, et al. Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia. Blood. 2014;123:3739–3749.
- Clappier E, Grardel N, Bakkus M, et al. IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children’s Leukemia Group study 58951. Leukemia. 2015;29:2154–2161.
- van der Veer A, Waanders E, Pieters R, et al. Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL. Blood. 2013;122:2622–2629.
- Boer JM, Koenders JE, van der Holt B, et al. Expression profiling of adult acute lymphoblastic leukemia identifies a BCR-ABL1-like subgroup characterized by high non-response and relapse rates. Haematologica. 2015;100:e261–e264.
- Roberts KG, Li Y, Payne-Turner D, et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med. 2014;371:1005–1015.